Clinical Trial Update: Spironolactone on Acute Kidney Injury in Critically Ill Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating spironolactone for acute kidney injury in critically ill patients; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: Acute Kidney Injury | Phase 3 | Status: UNKNOWN